Figure 2From: Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher diseaseEnzyme replacement therapy against standard medical therapy after Monte Carlo simulation of transition probabilities. (A) Scatterplot of undiscounted incremental medical costs and QALYs (B) corresponding cost-effectiveness acceptability curve.Back to article page